Cancer News and Research

Latest Cancer News and Research

TSRI scientists confirm that quality control steps exist to protect production of proteins

TSRI scientists confirm that quality control steps exist to protect production of proteins

Prostate Cancer Awareness Month: Myriad Genetics working to educate public about hereditary cancer risk assessment

Prostate Cancer Awareness Month: Myriad Genetics working to educate public about hereditary cancer risk assessment

Molecular life scientists to gather in Jerusalem for 2017 FEBS Congress

Molecular life scientists to gather in Jerusalem for 2017 FEBS Congress

BioCote Silver Ion Antimicrobial Technology makes surfaces inhospitable to influenza viruses

BioCote Silver Ion Antimicrobial Technology makes surfaces inhospitable to influenza viruses

PENTAX Medical and Hitachi Medical Systems Europe jointly launch new ultrasound video bronchoscope

PENTAX Medical and Hitachi Medical Systems Europe jointly launch new ultrasound video bronchoscope

Generation Genome: the UK’s genetics revolution?

Generation Genome: the UK’s genetics revolution?

Abdominal weight found to be key predictor of cancer risk in  postmenopausal women

Abdominal weight found to be key predictor of cancer risk in postmenopausal women

Study: Chemoradiation should remain standard treatment for locally advanced cervical cancer

Study: Chemoradiation should remain standard treatment for locally advanced cervical cancer

Combination immunotherapy as second or third line treatment of mesothelioma shows promising results

Combination immunotherapy as second or third line treatment of mesothelioma shows promising results

Study: Maintenance therapy increases progression-free survival in BRCA mutant recurrent ovarian cancer

Study: Maintenance therapy increases progression-free survival in BRCA mutant recurrent ovarian cancer

Penn researcher wins National Cancer Institute Outstanding Investigator Award

Penn researcher wins National Cancer Institute Outstanding Investigator Award

Study: Immunotherapy shows promising response rate in patients with metastatic gastric cancer

Study: Immunotherapy shows promising response rate in patients with metastatic gastric cancer

Two new treatments may benefit patients with high risk prostate cancer, trial shows

Two new treatments may benefit patients with high risk prostate cancer, trial shows

New recommendations advise against use of brain imaging as test for chronic pain

New recommendations advise against use of brain imaging as test for chronic pain

New trial confirms superiority of triplet regimen over standard care in resectable esophago-gastric cancer

New trial confirms superiority of triplet regimen over standard care in resectable esophago-gastric cancer

Alternative options could improve cervical cancer screening rate among transgender men, study shows

Alternative options could improve cervical cancer screening rate among transgender men, study shows

LORELEI trial: Treatment with alpha specific PI3K inhibitor reduces breast tumor size

LORELEI trial: Treatment with alpha specific PI3K inhibitor reduces breast tumor size

Follow-up letters, FIT tests can help improve colon cancer screening completion

Follow-up letters, FIT tests can help improve colon cancer screening completion

Scientists find new strategy for overcoming resistance to drugs in lung cancer patients

Scientists find new strategy for overcoming resistance to drugs in lung cancer patients

Research: Alcohol industry misrepresenting evidence about alcohol-related cancer risk

Research: Alcohol industry misrepresenting evidence about alcohol-related cancer risk

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.